相关实验视频
Updated: May 27, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.2K
国际合作,以提高对2型肌性缩症的知识
Stojan Peric1, Vukan Ivanovic1, Emma-Jayne Ashley2
1University Clinical Center of Serbia - Neurology Clinic, University of Belgrade - Faculty of Medicine, Belgrade, Serbia.
Journal of neuromuscular diseases
|February 20, 2025
概括
这项研究分析了TREAT-NMD网络中的1,720名2型肌肉性缩症 (DM2) 患者,揭示了关键的人口和临床数据. 这些发现突显了DM2注册的全球影响力,并为未来的研究和临床试验招聘提供了信息.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 全球TREAT-NMD注册网为神经肌肉疾病的研究提供了便利.
- 肌性缩症2型 (DM2) 被纳入了这个全球合作的努力.
- 注册表旨在改善合作研究和临床试验的机会.
研究的目的:
- 在TREAT-NMD网络中评估DM2患者的特征.
- 分析注册的DM2患者的社会人口和临床特征.
- 为未来的研究建立最大的DM2队列.
主要方法:
- 从TREAT-NMD肌性缩症核心注册表通过电子邮件调查收集数据.
- 包括来自10个参与注册表的DM2患者.
- 分析社会人口统计和临床数据.
主要成果:
- 在10个注册表中发现了1720例DM2病例.
- 捷克,德国和美国的患者入学率最高.
- 在中欧观察到高的DM2:DM1比率,登记时的平均年龄为51岁.
结论:
- 这项研究代表了迄今为止汇集的最大的DM2队列.
- 这些发现为未来的研究和试验招聘提供了关键的人口统计和临床数据.
- 该研究强调了TREAT-NMD的国际影响力和DM2数据收集的重要性.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Cross-bridge Cycle
116.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.6K
Disorders of the Skeletal Muscle
857
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
857
Myasthenia Gravis: Diagnostic Tests
601
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
601
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
650
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
650
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K

